Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.06.23 | Ascendis Pharma: One-Year Data from Phase 3 Trial of TransCon PTH in Adults with Hypoparathyroidism Presented at ENDO 2023 | 397 | GlobeNewswire (Europe) | - Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported for the initial 26-week blinded portion of the... ► Artikel lesen | |
17.06.23 | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023 | 280 | GlobeNewswire (Europe) | -- Mean BMI reduction of 21.0% from baseline observed in 13 patients at six months, showing progression from 16.8% mean BMI reduction at 16 weeks -- -- Phase 3 trial evaluating setmelanotide in acquired... ► Artikel lesen | |
17.06.23 | Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress | 363 | GlobeNewswire (Europe) | New data at week 36 shows atacicept 150 mg resulted in a delta of 43% versus placebo in mean proteinuria reduction in per-protocol analysis and demonstrated statistically significant stabilization... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 5.557 |
NVIDIA | 3.694 |
TUI | 3.066 |
GAMESTOP | 2.913 |
BAYER | 2.386 |
NEL | 2.212 |
RHEINMETALL | 1.876 |
BYD | 1.750 |
DEUTSCHE LUFTHANSA | 1.488 |
TESLA | 1.245 |
VOLKSWAGEN | 1.099 |
CARL ZEISS MEDITEC | 1.034 |
SUPER MICRO COMPUTER | 935 |
CAVENDISH HYDROGEN | 897 |
BASF | 868 |
APPLE | 862 |
AIXTRON SE | 848 |
THYSSENKRUPP | 828 |
COMMERZBANK | 825 |
DEFI TECHNOLOGIES | 802 |
PORSCHE SE | 719 |
DEUTSCHE BANK | 717 |
RENK GROUP | 688 |
MERCEDES-BENZ | 659 |
BIONTECH | 653 |